Depression linked to accelerated cognitive decline in diabetes

The ACCORD-MIND study was funded through an intra-agency agreement between the National Institute on Aging; the National Heart, Lung, and Blood Institute; and the National Institute on Aging Intramural Research Program. Study drugs, equipment, and/or supplies were provided by Abbott Laboratories, Amylin Pharmaceuticals, AstraZeneca, Bayer HealthCare, Closer Healthcare, GlaxoSmithKline, King Pharmaceuticals, Merck, Novartis, Novo Nordisk, Omron Healthcare, Sanofi-Aventis, and Schering-Plough.